Latham Wins Dismissal of Securities Action Involving Liver Disease Drug Developer

The case involved a clinical trial of Akero’s only product, a drug candidate aimed at treating a liver disease. It’s the second time U.S. District Judge Yvonne Gonzalez Rogers has ordered dismissal.

       

The case involved a clinical trial of Akero’s only product, a drug candidate aimed at treating a liver disease. It’s the second time U.S. District Judge Yvonne Gonzalez Rogers has ordered dismissal.